MP
ERAS icon

Mangrove Partners’s Erasca ERAS Stock Holding History

Mangrove Partners’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$288K Buy
+15,699
New +$225K 0.02% 279

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Mangrove Partners's ERAS Position: Q2 2026 in Review

Mangrove Partners opened a new position in Erasca (ERAS) in Q2 2026: 15,699 shares worth $288K. The stake represents 0.02% of the portfolio and ranks #279 among its holdings.

257 funds tracked by Wall St. Rank hold ERAS as of Q2 2026.

  • Mangrove Partners held 15,699 shares of Erasca worth $288K as of Q2 2026.
  • Erasca was a new Mangrove Partners position in Q2 2026.
  • Erasca made up 0.02% of Mangrove Partners's portfolio in Q2 2026, its #279 holding.
  • 257 funds tracked by Wall St. Rank held Erasca as of Q2 2026.

Based on Mangrove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.